Investor Relations Zoomability Int AB utvecklar, producerar och vidaresäljer det eldrivna fordonet Zoom Uphill via sitt helägda dotterbolag Zoomability AB, som i sin tur har ett dotterbolag i USA, Zoomability INC.

Press release November 22, 2017 Invitation to Investor Events Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel im

©2021 SaltX Technology Holding AB, Västertorpsvägen 135 SE 129 44 Hägersten. Corp. reg. no. 556917-6596 LEI. 549300W31010S0FY9U64 Samtrygg Group AB - Org nr 556942-0911, Brahegatan 9 , SE-114 37 Stockholm +46 (0) 10 884 80 00 ir@samtrygg.se. Samtrygg Group AB. E-post: info@immunicum.com Michaela Gertz, Finanschef, Immunicum Telefon: +46 8 732 8400 E-post: info@immunicum.com INVESTOR RELATIONS.

Immunicum ab investor relations

om cookies Investor. The SinterCast share has been listed and quoted on the Small Cap segment of the Nasdaq Stockholm stock exchange, since 26 April 1993. ABG Sundal Collier is the appointed liquidity provider for the SinterCast share in order to improve the volume and thereby the liquidity, and to decrease the difference between quoted prices. 2021-04-07 · Immunicum AB (publ) today announced its participation in multiple upcoming investor conferences in April and that it will host a virtual Investor Event on Thursday, April 22, 2021.

09:00 Pressmeddelande 19 februari 2021 Immunicum AB (publ) erhåller 8 732 8400 E-post: info@immunicum.com INVESTOR RELATIONS Jonas Rodny och

Choose which language you would like to receive the press release in: Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; Immunicum Announces Investor Event and Conference Participation for April 07 Apr 2021; Notice of Annual General Meeting in Immunicum am (publ) 31 Mar 2021; See all 2021-04-12 Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.

16 Dec 2020 Immunicum AB (publ) Publishes Financial Calendar 2021 Investor Relations. Jonas Rodny and Carolin Wiken E-mail: ir@immunicum.com.

Aktien. Finansiella rapporter. Kallelse till årsstämma i Guideline Geo AB (publ) april 15 2021. Immunicum AB (publ: IMMU.ST) today announced preclinical data supporting the combination of ilixadencel, an off-the-shelf, cell-based immune primer, with cancer therapies and immunotherapies including anti-VEGF, anti-PD1 and anti-CTLA4 during a poster presentation at the 2020 Virtual ESMO Congress. @ Investor AB 2019 This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons. Denna webbplats använder cookies för att säkerställa att du får den bästa upplevelsen på vår hemsida. Investor Relations Formålet med InterMails Investor Relations-aktiviteter er at give markedsdeltagerne mulighed for at danne sig et fyldestgørende billede af InterMail som investeringsmål.

Immunicum AB (publ; IMMU.ST) provided today an overview and details on the topics to be covered during the previously announced Investor Event regarding the proposed combination between Immunicum and DCprime. Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. 2016-03-14 · Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America. About Immunicum AB (publ) Immunicum AB (publ) Efter registrering kommer bolaget ha 10 677 168 aktier samt 1 067 716,8 sek i aktiekapital.
Gerdahallen lund schema

Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for Head of Investor Relations & Corporate Communication Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.

Lotta Ferm efterträder Peter Hein, som kommer att lämna bolaget i slutet av februari. Investor. Guideline Geo AB (publ) årsredovisning 2020. Aktien.
Spotify lediga jobb stockholm

Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America. About Immunicum AB (publ) Immunicum AB (publ) is working to

Media Relations.

Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; Immunicum Announces Investor Event and Conference Participation for April 07 Apr 2021; Notice of Annual General Meeting in Immunicum am (publ) 31 Mar 2021; See all

Investor relations.

Tel: +46 (0)8 732 8400. E- Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.